Kevin Cady
CEO and Founder
OnPoint Vision, Inc.
The startup develops intraocular pseudophakic contact lenses that correct residual refractive errors in patients post-cataract surgery. Their technology also targets visual decline caused by age-related retinal pathologies, providing a minimally invasive solution to enhance visual outcomes.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Many patients who undergo cataract surgery still experience residual refractive errors, leading to suboptimal visual outcomes. Additionally, age-related retinal pathologies, such as macular degeneration, can cause visual decline that is not adequately addressed by existing solutions.
Solution
OnPoint Vision develops and manufactures intraocular pseudophakic contact lenses (IOPCLs), including the AccuraSee™ IOPCL (CadyLens), designed to correct residual refractive error in pseudophakic patients. The AccuraSee™ IOPCL is a biocompatible silicone lens implanted in the capsular bag, coupled with an existing posterior chamber lens, to fine-tune vision without the risks associated with sulcus placement. The company is also developing the AccuraSee™ IOPCL AMD Mag, a customized lens technology designed to deliver magnified vision for pseudophakic patients with low vision due to advanced stage age-related macular degeneration (AMD). This lens serves as a near magnifier when the pupil constricts and converges, while the peripheral area remains neutral for distance vision.
Target Audience
The primary target audience includes ophthalmic surgeons seeking to improve visual outcomes for pseudophakic patients with residual refractive errors or those experiencing visual decline due to age-related macular degeneration.
Features
- AccuraSee™ IOPCL: A neutral spherical optic made of biocompatible silicone (Biosil™) designed for secondary implantation in the capsular bag.
- Addresses residual refractive errors post-cataract surgery.
- AccuraSee™ IOPCL AMD Mag: A customized lens for patients with low vision due to advanced stage AMD.
- Provides magnified near vision through pupil constriction and convergence.
- Features a neutral peripheral area for distance vision.
- Minimally invasive surgical solution.
- Fully reversible for refractive power adjustment or multifocal reversibility.
- Can be customized for astigmatic correction, cornea asymmetry, and multifocality.